Additionally, EVs carrying inhibitory ligands, such FasL, interfere with the Fas/Fas-ligand pathway and induce apoptosis of activated T cells following cancer vaccines or adoptive T or NK cell therapy [89,90,91]. This evidence concerns the gene FASLG and cancer.